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ABSTRACT - Background - Laparoscopic pancreatic resections have become 
increasingly frequent with good results reported by several centers. However, 
few studies have focused on laparoscopic treatment of pancreatic cystic lesions. 
Aim - To analyze the results of minimally invasive treatment of pancreatic cystic 
lesions. Methods - Were included all laparoscopic pancreatic resections performed 
at three centers. Surgical procedures included resection of the pancreas and left 
enucleations (with or without splenectomy). The post-operative complications 
were classified according to the classification proposed by Clavien and Dindo6. The 
diagnosis of pancreatic fistula was confirmed if the amylase dosage of the drainage 
liquid in the third postoperative day was more than three times the amount of 
serum amylase. Results - Were performed 44 laparoscopic pancreatic resections. 
Fifteen patients underwent surgery for suspected pancreatic cystadenoma and 13 
had this diagnosis confirmed. There were 12 women (92%), and the average age of 
patients was 50 years. Six patients had minor postoperative complications. There 
were five (38%) pancreatic fistulas, neither considered as severe (C), and only one 
patient required hospital readmission and radiological drainage. In this series, there 
were no conversions, reoperations, or mortality. Conclusions - The laparoscopic 
approach is a safe and effective option for the treatment of pancreatic cystic lesions. 
The incidence of pancreatic fistula has good evolution and not diminishes the 
benefits of minimally invasive surgery.
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RESUMO - Racional - As ressecções pancreáticas por laparoscopia tem se tornado cada 
vez mais frequentes, com bons resultados relatados por vários centros.  Entretanto, 
poucos estudos se concentraram no tratamento laparoscópico das lesões císticas 
pancreáticas. Objetivo - Analisar os resultados do tratamento minimamente invasivo 
das lesões císticas pancreáticas. Métodos - Análise retrospectiva de um banco de 
dados prospectivo multicêntrico brasileiro. Foram incluídas todas as ressecções 
pancreáticas laparoscópicas realizadas em três centros. Os procedimentos 
cirúrgicos incluíram enucleações e ressecções do pâncreas esquerdo (com ou sem 
esplenectomia associada). As complicações pos-operatórias foram classificadas de 
acordo com a classificação proposta por Clavien e Dindo6. O diagnóstico de fístula 
pancreática foi confirmado se a dosagem de amilase do líquido de drenagem no 3o 
dia pós-operatório era superior a três vezes o valor da amilase sérica. Resultados 
- Foram realizadas 44 ressecções pancreáticas por laparoscopia. Quinze pacientes 
foram operados com suspeita de cistoadenoma pancreático e 13 tiveram o 
diagnóstico confirmado. Foram operadas 12 mulheres (92%), e a idade média foi 
de 50 anos. Seis pacientes tiveram complicações pós-operatórias leves. Ocorreram 
cinco (38%) fístulas pancreáticas, nenhuma considerada grave (C) e apenas um 
paciente necessitou re-internação hospitalar e drenagem radiológica. Nesta série 
não houve conversões, re-operações ou mortalidade. Conclusões - O acesso 
videolaparoscópico é opção segura e eficaz para o tratamento das lesões císticas 
pancreáticas. As fístulas pancreáticas são quase sempre de evolução favorável e não 
diminuem os benefícios do acesso minimamente invasivo.
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INTRODUCTION
Cystic neoplasms of the pancreas comprise 15-20% of pancreatic cystic lesions and approximately 10% of all pancreatic 
cancers1,2. Although infrequent, and with no specific 
symptoms, it has been observed an increase in diagnosis 
of the so called “incidental lesions”, mostly because 
of technological improvement of diagnostic imaging 
methods. Belongs to this large group of neoplasms, a 
number of heterogeneous tumors which present very 
similar clinical and laboratory characteristics, however, 
with totally different prognosis23,24.
Cystic lesions of the pancreas may be divided into three 
groups according to their epithelial lining: 1) no epithelial 
lining (pseudocysts), 2) presence of epithelial lining (serous 
cystadenomas and mucinous cystadenomas), 3) presence 
of degeneration of the epithelial lining or solid lesions 
(solid-cystic papillary tumors, ductal adenocarcinomas, and 
neuroendocrine tumors).
Pancreatic cystadenomas, which surgical treatment 
constitutes the focus of this article, are classified 
according to their histopathological characteristics1,5,15: 
1) serous cystic neoplasms (serous cystadenoma and 
serous cistoadenocarcinoma); 2) mucinous cystic 
neoplasm (mucinous cystadenoma, and mucinous 
cystadenoma with moderate dysplasia); 3) mucinous 
cistoadenocarcinoma, which can be divided into non-
infiltrating and infiltrating.
Laparoscopic pancreatic resections have become 
increasingly frequent, with excellent results reported by 
several centers7,10,19,26. However, few studies have focused 
on laparoscopic treatment of pancreatic cystic lesions. 
The aim of this study is to analyze the results of a 
minimally invasive approach to cystic pancreatic lesions.
METHODS
This study is a retrospective analysis of a prospective 
collected database started in 2006. Were included all 
laparoscopic pancreatic resections performed in three 
centers (Service of General and Oncologic Surgery, 
Hospital do Servidor Público Estadual de São Paulo; 
Department of Digestive Surgery, Universidade Federal 
de São Paulo; Service of Oncologic Surgery of Cuiabá, MT, 
Brazil). The procedures performed included enucleations 
and distal pancreatectomies (with or without splenectomy). 
Preoperatively patients were given anti-pneumococcal 
vaccination (two weeks before surgery) and antibiotic 
prophylaxis (at general anesthesia induction and two 
additional doses at POD 1). Liquid diet was started in 
the first or second POD. The most common surgery 
performed was distal pancreatectomy with splenectomy. 
Surgical technique
Patient was placed in supine position with the surgeon 
standing between the patient’s legs. The first assistant stands 
on the patient’s right side (camera and forceps traction), 
and the second on the left of the patient. Five portals were 
used: 1) a 10 mm supra-umbilical (optical); 2) a 12 mm in 
the left hypochondrium (for dissection and stapler firing); 3) 
a 5 mm in the right hypochondrium (dissection); 4) a 5 mm 
in epigastrium (presentation); and 5) 5 mm on the left flank, 
if needed for presentation. The operation began with the 
opening of gastrocolic ligament beneath the gastroepiploic 
vessels for pancreas visualization and identification of the 
lesion. Omental complete section was performed from 
medial to lateral including the splenocolic ligament, also 
divided. Thus, was perform the dissection of the splenic 
artery in its middle third (in some cases was chosen just to 
tie with no division of the artery at this point). Dissection 
continued at the lower edge of the pancreas, with section 
of the root of the mid-colon. The inferior mesenteric vein 
and the splenic vein were visualized, freed, and the splenic 
vein was then ligated and divided. A retropancreatic tunnel 
was dissected and the pancreas divided with staplers 
(Wirsung´s duct, if identified, was sutured separately with 
3-0 prolene). The splenic artery was then ligated and 
divided (which is extremely facilitated once the pancreas 
has been sectioned). The surgery ended with the complete 
mobilization of the splenopancreatic block. Was usually 
leaved a closed-suction drain in the sub-diaphragmatic 
space. Removal of the surgical specimen was usually done 
through a Pfannestiel incision. 
Postoperative complications were classified 
according to the classification proposed by Clavien 
and Dindo6. The diagnosis of pancreatic fistula was 
confirmed if a drain output of any measurable volume 
of fluid on or after postoperative day 3 showed amylase 
content greater than three times the serum amylase 
activity, and were classified by the ISGPF statement2.
RESULTS
Between June/2006 and March/2012 were performed 
44 laparoscopic pancreatic resections. Fifteen patients 
underwent surgery for suspected pancreatic cystadenoma, 
and 13 had this diagnosis confirmed and two patients were 
classified as pancreatic pseudocysts. There were 12 women 
(92%), and the median age of patients was 50 years (33-74). 
The types of resections, the postoperative complications 
and the size of lesions are shown in Table 1.
There were no conversions, re-operations 
or mortality in this series. Six patients had minor 
postoperative complications (Dindo and Clavien 
classification categories I or II)6. One of the two patients 
who presented pancreatic fistulas classified as type B 
of Bassi et al. classification2, required re-hospitalization 
and a percutaneous image-guided drainage. Of the 
13 patients confirmed to have cystadenomas at final 
pathological examination, there were seven (54%) 
mucinous cystadenomas, one macrocystic serous 
cystadenoma (one man), and three microcystic serous 
cystadenomas (Figure 1).
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DISCUSSION
Diagnosis of pancreatic cystadenomas is a true 
dilemma12. The lesions are very often completely 
asymptomatic or have nonspecific symptoms. The use 
of data such as age, sex, personal antecedents, general 
health status, among others, can help in formulating a 
diagnosis. (Figure 2)
The criteria for the diagnosis of pancreatic cystic 
neoplasms are obtained from imaging methods 
(morphology), aspirated fluid analysis (cytology and 
tumor markers), and the histological analysis of the 
surgical specimen4,5,8. Figure 3 summarizes the expected 
results of the cyst´s fluid analysis
The highest frequency of lesions in female patients 
(92%), the mean age (50 years) and the distribution of 
the lesions (54% of mucinous lesions) in this study are 
similar to the literature1,4,5. 
Serous cystadenoma is considered a benign 
disease by histopathological characteristics and 
outcome, with a chance of malignant transformation of 
less than 1%. A recent review of the literature reports 
only 27 cases of serous cystadenocarcinoma3. Although 
there is no consensus, especially in asymptomatic cases, 
regarding the therapeutic approach there is a trend in 
specialized centers to indicate the resection of all cystic 
lesions larger than 4 cm1,3,5,9,11,12,13.
Contrary to serous tumors, mucinous lesions 
are considered high-risk lesions of malignant 
transformation. Different studies have shown the 
presence of carcinoma in situ or invasive carcinoma in 
34-48% of operated mucinous cystadenomas. Mucinous 
neoplasms are most commonly find in females between 
the 4th and 5th decades of life (over 80% of cases). 
Although most of these lesions are asymptomatic, 
some symptoms, in particular loss of weight and / or 
severe pain, if presented, should rise the suspicion of an 
associated malignant transformation. Once diagnosed, 
surgical resection is considered the treatment of choice 
for mucinous cystic neoplasms1,3,5,9,11,12,13.
Pancreatic fistula is the most frequent 
complication of distal pancreatectomy regardless of the 
approach14,17,19,21,26. The frequency of pancreatic fistula in 
this study (38%) is similar to the literature10,16,17. Several 
techniques and pitfalls have been proposed to reduce 
this complication, such as suture reinforcement20, 
individual ligation of Wirsung´s duct20, different types 
mechanical staples loads22, coating of suture lines with 
absorbable material25, and very slow closure of the 
stapler18. Taken together, these results are controversial 
and do not, so far, indicates a particular technique.
There are no sufficient studies in the literature to 
TABLE 1 - Patient´s characteristics and postoperative results 
of 13 laparoscopic resections for pancreatic 
cystadenomas
Characteristics N (%)
Sex
    - man   1 (7,6%)
    - women 12 (92,4%)
Age (median) 33-74 (50,2 years)
Tumor´s size (cm) 2 – 10 cm (median 4,5cm)
Duration of operation (min.) 120-240 min (160 min)
Type of surgery
    - enucleation 2 (serous cystadenomas)
    - DP with spleen preservation 1 (mucinous cystadenoma)
    - DPS 10 
Blood transfusion 1 (7,6%)
Hospital lenght of stay 5,2 days (4-9)
Clinical complication 1 (atelectasia)
Pancreatic fistula (Bassi et al.2) 5 (38%)
    A 3 
    B 2
    C - 
DP: distal pancreatectomy ; DPS: distal pancreatectomy with splenectomy
FIGURE 1 – A) Macrocystic cistoadenoma; B) mucinous 
cistoadenoma
Neoplasia Sex Age % of CNP Prognosis
SCA Women 60-70 32 – 39 Very low potential of malignity 
MCA Women 50-60 21 – 33 Potential of malignity 
IPMN no differences 60-70 21 – 33
Variable potential of 
malignity 
SCT 
(Frantz) Women 20-30 < 10 
Slow growing 
neoplasia. Metastatic 
potential 
SCA, Serous cystadenoma ; MCA, mucinous cystadenoma ; CNP, cystic neoplasia 
of the pancreas; IPMN, intra-ductal papillary mucinous neoplasia; SCT, 
pseudopapillary solid-cystic tumor of the pancreas (Frantz´s tumor)
FIGURE 2 - Clinical and epidemiological characteristics of 
primary cystic neoplasms of the pancreas, 
adapted from Brugge et al.4
Marker SCA MCA IPMN SCT 
CEA low high high low
CA 72-4 low high high unknown
CA 19-9 variable variable variable unknown
CA 125 low variable low unknown
CA 15-3 low high low unknown
Amilase low low high low
SCA, Serous cystadenoma ; MCA, mucinous cystadenoma ; CNP, cystic neoplasia 
of the pancreas; IPMN, intra-ductal papillary mucinous neoplasia ; SCT, 
pseudopapillary solid-cystic tumor of the pancreas (Frantz´s tumor)
FIGURE 3 - Concentration of tumor markers and amylase in 
the aspirated fluid      of cystic neoplasms of the 
pancreas, adapted from Brugge et al.4
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recommend the laparoscopic approach in confirmed 
cases of malignancy; so, a complete preoperative 
investigation should be performed and if relevant 
diagnostic doubt persists, the indication of the 
laparoscopic approach should be discussed individually.
CONCLUSION
Laparoscopic approach is a safe and effective 
option for the treatment of pancreatic cystic lesions. 
The incidence of pancreatic fistula has good evolution 
and not diminishes the benefits of minimally invasive 
surgery.
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